Queen’s University Belfast Featured PhD Programmes
University of Kent Featured PhD Programmes
King’s College London Featured PhD Programmes
University of Liverpool Featured PhD Programmes
University College London Featured PhD Programmes
"cardiovascular" AND "dis…×
10 miles

cardiovascular disease PhD Projects, Programs & Scholarships

We have 96 cardiovascular disease PhD Projects, Programs & Scholarships

  • "cardiovascular" AND "disease" ×
  • clear all
Order by 
Showing 1 to 10 of 96
  Functional coronary artery disease genetics: investigating the role of the candidate gene in models of In vivo cardiovascular disease
  Dr G Douglas, Prof K Channon
Application Deadline: 26 July 2019
Despite significant advancements in its treatment coronary artery disease is the leading cause of death in both the UK and world wide, accounting for over 66,000 deaths in the UK each year.
  Genetics of inherited cardiovascular disease: Using molecular genetic analysis of cardiovascular disease as a tool to define disease mechanisms and therapeutic targets.
  Prof H Watkins, Prof H Ashrafian, Prof C Redwood, Prof M Farrall
Application Deadline: 26 July 2019
Using molecular genetic analysis of cardiovascular disease as a tool to define disease mechanisms and therapeutic targets.
  Go with the flow: the why and how of cardiovascular disease
  Dr E Tzima
Application Deadline: 26 July 2019
Have you ever wondered why and how cardiovascular disease and atherosclerotic plaques develop in the areas that they do? Why is it that some arteries are prone to blockage while others are protected? The answer lies with blood flow.
  Estimating excess rates of disease-specific morbidity and mortality in cardiovascular disease patients
  Dr M Sweeting, Dr P Lambert
Application Deadline: 15 April 2019
Linkage of large-scale disease registry and population electronic health record (EHR) data has huge potential to address key questions regarding the life-course of patients following a cardiovascular disease (CVD) diagnosis, determining whether there are excess rates of comorbidity and determinants of variations in excess rates.
  Novel approaches for treating cardiovascular disease
  Dr J Erickson
Applications accepted all year round
Cardiovascular disease is the primary cause of death throughout most of the world, and existing therapeutic options are unsuitable for a large percentage of patients.
  The molecular mechanisms underpinning individual variation in platelet function and their effect on the progression and treatment of cardiovascular disease.
  Dr CI Jones
Applications accepted all year round
Platelets are small blood cells that play a vital role in the chronic and acute progression of Cardiovascular Disease (CVD). Platelets respond to a range of agonists, which are released when blood vessels are damaged, by aggregating together to form thrombi.
  Blood-brain barrier (BBB) dysfunction in cardiovascular disease
  Dr A Patabendige, Prof G Grau
Application Deadline: 31 March 2019
Irregular and rapid heartbeat can lead to cardiovascular disease, including heart failure, blood clots and stroke, affecting millions of people worldwide.
  Vascular health in the obese heart: A mechanism for the ‘obesity paradox’ for cardiovascular disease
  Prof GYH Lip, Dr VS Sprung, Dr A Shantsila
Applications accepted all year round
An ‘obesity paradox’ is evident in relation to cardiovascular disease, where obese patients seem to have better cardiovascular outcomes [Stroke.
  Genetic Epidemiology of Cardiovascular Disease: Studying genetic variation in cardiomyopathy and coronary artery disease across the entire allele frequency spectrum in order to identify causative genes and susceptibility loci.
  Prof M Farrall, Dr AG Goel
Application Deadline: 26 July 2019
Studying genetic variation in cardiomyopathy and coronary artery disease across the entire allele frequency spectrum in order to identify causative genes and susceptibility loci.
  Investigating the molecular mechanisms and consequences of ANP aggregation for cardiovascular disease; a computational and experimental approach
  Dr J Madine, Dr D J Rigden, Dr M Winn
Applications accepted all year round
Atrial natriuretic peptide (ANP) is a cardiovascular hormone synthesised and secreted by myocytes in the atrial wall where it regulates atrial blood volume and vasodilation.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.